WashU Medicine-led trial evaluating investigational drug from Eli Lilly and Company aims to stop disease before symptoms arise
Researchers at Washington University School of Medicine in St. Louis have enrolled the first participants in an international clinical trial designed to prevent Alzheimer’s disease in young adults at high risk. The study aims to determine whether halting early molecular changes associated with the disease can prevent its onset altogether.
The trial is enrolling participants as young as 18 who show few or no…